On April 13 at 10:45 am (ET), partners Daniel Alvarez and Kara Baysinger will participate as speakers on the panel titled “Steering Through Cyber Fishtails and Lock-ups: Responding to Cyber Threats at Full Speed.” The panel is part of the 2026 National School on Market Regulation, hosted...

Willkie partner Gavin Gordon, Chair of the European Private Equity Practice Group and a member of the Firm's Executive Committee, was profiled by Law360 as part of its UK Expert Analysis series. The in-depth article addressed emerging issues in the private equity industry, the keys to...

Willkie represented XGS Energy, a developer of next-generation geothermal power systems, in its partnership with Baker Hughes, an energy technology company, to develop a 150-megawatt geothermal project in New Mexico. XGS and Baker Hughes recently announced a strategic collaboration and...

Willkie advised Insight Partners as lead investor in a $130 million Series C funding round for ScaleOps, a leading platform for autonomous cloud and AI infrastructure resource management. On March 30, ScaleOps announced that it raised $130 million in Series C funding at a valuation exceeding...

Kim Jones, a partner in Willkie’s Litigation Department and ERISA Litigation Group, has been elected to the Fellows of the American Bar Foundation.   ABF Fellows are a global honorary society of attorneys, judges, law faculty and legal scholars whose public and private careers have demonstrated...

Willkie is representing Stifel, Nicolaus & Company, Incorporated, as sales agent, in connection with the SEC-registered at-the-market equity offering by Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer cell therapies to treat autoimmune...

New York, NY (March 30, 2026) — Willkie Farr & Gallagher LLP today announced that Miroslav Tomo will join the Firm as a partner in London. He will be a member of the Corporate & Financial Services Department and the Private Equity Practice Group. Gavin Gordon, Chair of Willkie’s European...

Willkie is representing CVC Capital Partners in the sale of 37% of its stake in Syntegon, a leading technology company and strategic partner to the pharmaceutical, biotechnology and food industries, to an investor group led by Apollo-managed funds. CVC recently announced that an Apollo-led...